Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Yasir B. Al-wakeel currently holds 49,579 shares of Neon Therapeutics, Inc. (NTGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Yasir B. Al-wakeel has been a net buyer of NTGN stock. They have purchased $99.8K and sold $32.5K worth of shares.
Yasir B. Al-wakeel's most recent insider trade was on Jun 17, 2026, when they sold 49,579 shares at $0.00 per share.
Yasir B. Al-wakeel serves as Executive at Neon Therapeutics, Inc. (NTGN). They have executed 18 insider transactions totaling $132.3K over their tenure at the company.
Yasir B. Al-wakeel holds the position of Executive at Neon Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Yasir B. Al-wakeel has shown a buying trading pattern, with $99.8K in total purchases and $32.5K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Yasir B. Al-wakeel was on Jul 17, 2018, when they sold $100.0K worth of NTGN shares. This transaction involved 17,241 shares at $5.80 per share.
Yasir B. Al-wakeel currently owns 49,579 shares of Neon Therapeutics, Inc. (NTGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Yasir B. Al-wakeel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Yasir B. Al-wakeel has 18 Form 4 filings on record as an insider at Neon Therapeutics, Inc..
Set alerts for Yasir B. Al-wakeel and 40,000+ other insiders.